Seres Therapeutics Inc. (MCRB)
NASDAQ: MCRB
· Real-Time Price · USD
7.46
-0.04 (-0.53%)
At close: Jun 16, 2025, 3:59 PM
7.54
1.14%
After-hours: Jun 16, 2025, 06:24 PM EDT
-0.53% (1D)
| Bid | 7.3 |
| Market Cap | 65.1M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 72.95M |
| EPS (ttm) | -7.95 |
| PE Ratio (ttm) | -0.94 |
| Forward PE | -0.94 |
| Analyst | Hold |
| Ask | 8.27 |
| Volume | 24,472 |
| Avg. Volume (20D) | 94,444 |
| Open | 7.55 |
| Previous Close | 7.50 |
| Day's Range | 7.44 - 7.59 |
| 52-Week Range | 6.53 - 30.60 |
| Beta | 2.62 |
About MCRB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MCRB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MCRB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-16.04%
Seres Therapeutics shares are trading lower after ...
Unlock content with
Pro Subscription
6 months ago
+3.83%
Seres Therapeutics shares are trading higher after the company announced that SER-155 received FDA breakthrough therapy designation for its bloodstream infection reduction.
